What Causes Keratoconus? Genetics, Triggers, and Care

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on eye & vision health. Browse all Eye & Vision Health education

Keratoconus is a progressive eye disorder in which the normally dome-shaped cornea thins and bulges into an irregular cone. That distortion scatters incoming light, producing blurred, doubled, or ghosted vision that glasses struggle to correct. It usually appears in the teens or twenties and can advance for years. Understanding its causes — genetic, environmental, and hormonal — helps people seek care early, when intervention matters most.

What Happens to the Cornea

The cornea is the clear front window of the eye, and its precise curvature is what focuses light onto the retina. In keratoconus, the collagen scaffolding that keeps the cornea rigid weakens, so the tissue thins and steepens into a cone. As the shape becomes more irregular, vision blurs and distorts, glare and halos increase, and prescriptions change frequently. In advanced cases, corneal scarring can further reduce clarity.

The Causes Behind Keratoconus

Keratoconus is multifactorial. Mechanical stress on the cornea is a major modifiable driver — chronic, vigorous eye rubbing is one of the most consistently reported risk factors. It is more common in people with allergic eye disease and atopic conditions, and it has well-documented associations with connective-tissue disorders and with Down syndrome.

Hormonal changes may play a role too: onset and progression often cluster around puberty and pregnancy, periods of significant hormonal shift. And there is a clear familial pattern — having a close relative with keratoconus raises the odds, pointing to genetic susceptibility layered on top of environmental triggers.

The Genes Linked to Keratoconus

Several named genes have been associated with keratoconus, most tied to how the cornea builds and maintains its collagen structure. VSX1, a transcription factor active in corneal development, was among the first implicated. ZNF469 is strongly associated with corneal thickness and connective-tissue integrity, and variants here are among the more consistently replicated findings.

Genes governing collagen and its cross-linking — COL5A1 and LOX (lysyl oxidase) — also influence corneal biomechanical strength, and TGFBI participates in corneal matrix biology. These variants shape a tendency toward a thinner or more pliable cornea; they are pathway-level influences, not a certainty that keratoconus will develop.

Detection and Evidence-Based Care

Early keratoconus can hide behind an ordinary-looking eye exam, which is why corneal topography and tomography — detailed maps of corneal shape and thickness — are the standard tools for detection. Catching it early opens the door to interventions that can slow progression. Corneal cross-linking, an established procedure that strengthens collagen bonds, is used to stabilize progressing keratoconus, while specialty contact lenses and, in advanced cases, corneal transplantation restore vision.

This is general educational information. Diagnosis, monitoring, and any procedure are decisions for an eye-care professional — an optometrist or ophthalmologist — based on your individual corneal measurements.

Where Genetic Pathway Insight Fits

Genetic testing does not diagnose keratoconus — corneal imaging does that — and PlexusDx makes no claim to detect, treat, or prevent it. What pathway-level insight can offer is context about connective-tissue and collagen-related biology, informed by variants in genes such as ZNF469 and COL5A1. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across the biological pathways that intersect with tissue structure and repair.

Paired with an eye-care professional's exam, that upstream context can help you understand your baseline biology and make proactive decisions — genetics as a guide, not a guarantee.

Frequently Asked Questions

Is keratoconus hereditary?

Genetics contributes, but keratoconus is multifactorial. Having a close relative with the condition raises your risk, and named genes like ZNF469 and VSX1 influence corneal structure. However, environmental factors — especially chronic eye rubbing and allergic eye disease — also drive it. Family history is a reason for early screening, not a certainty.

Can eye rubbing really cause keratoconus?

Vigorous, chronic eye rubbing is one of the most consistently reported risk factors and can accelerate progression in susceptible people. It is thought to add mechanical stress to an already weaker cornea. Managing underlying allergies and avoiding hard rubbing are common, evidence-based recommendations from eye-care professionals.

Does a keratoconus gene mean I will lose my vision?

No. Variants in genes like COL5A1 or ZNF469 influence corneal biomechanics but do not guarantee keratoconus, let alone blindness. Early detection through corneal topography and treatments such as cross-linking can stabilize vision. Genetic variants are a pathway-level tendency interpreted alongside eye exams, not a verdict.

Can genetic testing diagnose keratoconus?

No. Only corneal imaging — topography and tomography performed by an eye-care professional — can detect and diagnose keratoconus. Pathway-level genetic insight describes tendencies in connective-tissue and collagen pathways involving genes such as ZNF469. It offers proactive context, not a diagnosis or a substitute for an eye exam.

Curious about the genetic pathways behind your own biology? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights to give you pathway-level context you can bring to your provider — because with PlexusDx, you know your biology instead of guessing about it.

This article is part of the PlexusDx Education Hub. Browse all Eye & Vision Health education

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.